shared a post on LinkedIn:
“Honored to be a featured MPN faculty speaker for this upcoming MD Anderson Cancer Center Research Town Hall with focus on Myelofibrosis: The Next Frontier MPN – Stephen Oh, Prithviraj Bose, Naveen Pemmaraju, Lucia Masarova, Sanam Loghavi.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.